Back to Top
Brayton Purcell LLP
Call for A Free Consultation
Nationwide Service for over 30 years

April 2005 Archives

Celebrex® Label Insert May Include New Warning

Arthritis Drug Bextra® Withdrawn from the Market WASHINGTON, D.C. -- April 13, 2005 -- The drug manufacturer, Pfizer, has withdrawn Bextra® (valdecoxib), from the market at the request of the Food and Drug Administration (FDA). Bextra® is used to relieve the symptoms of osteoarthritis and rheumatoid arthritis. However, the drug...

A Letter to Sen. Arlen Specter About Harmful Asbestos Legislation

Brayton Purcell has been in the forefront of the fight against proposed legislation that would benefit asbestos-affiliated companies at the expense of asbestos victims. The law firm's senior trial partner, Gilbert Purcell, wrote the following letter to Senator Arlen Specter: The Hon. Arlen Specter United States Senator Chair, Senate Judiciary...